|
|
|
40
|
A3951
|
SERETIDE DISKUS 500MCG | 50MCG INHR (GSK/COL) F
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
A
|
60.97
|
60.97
|
INHALER
|
0
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
CHANGE FROM CAT C -CAT A
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
0000-00-00
|
|
|
|
41
|
A3951
|
SERETIDE DISKUS 500MCG|50MCG INHR (GSK)
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
A
|
64.1
|
64.0981
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3951
|
SERETIDE DISKUS 500MCG|50MCG INHR (GSK) FLUTICASONE|SALMETER
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
A
|
67.31
|
67.31
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3954
|
FLUTICASONE | SALMETEROL 500MCG | 50MCG INHR (CIP/AHI)
|
FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
60 DOSES
|
A
|
53.58
|
53.58
|
INHALER
|
1
|
INHR
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
40
|
A3961
|
SERETIDE MDI 250MCG | 25MCG INHR (GSK/COL) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
62.17
|
62.17
|
INHALER
|
0
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3961
|
SERETIDE MDI 250MCG|25MCG INHR (GSK) FLUTICASONE|SALMETEROL (C)
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
68.39
|
68.393
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3961
|
SERETIDE MDI 250MCG|25MCG INHR (GSK) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SERETIDE MDI
|
120 DOSES
|
C
|
71.82
|
71.82
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3965
|
COMBIWAVE 250MCG | 25MCG INHR (GLP/ALI) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
C
|
32.62
|
32.62
|
INHALER
|
0
|
INHR
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ALI
|
ALL HEALTH INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2022-03-22
|
Delete from contract
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
2022-03-22
|
|
|
|
40
|
A3966
|
SEROFLO 250MCG | 25MCG INHR (CIP/AHI) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SEROFLO
|
120 DOSES
|
A
|
39.96
|
39.96
|
INHALER
|
1
|
INHR
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3966
|
SEROFLO 250MCG|25MCG MDI (CIP) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
SEROFLO
|
120 DOSES
|
A
|
37.92
|
37.9206
|
INHR
|
1
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A3969
|
RELVAR ELLIPTA 200MCG | 25MCG INHR (GSK/COL) FL
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
44.25
|
44.25
|
INHALER
|
1
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A3969
|
RELVAR ELLIPTA 200MCG|25MCG INHR (GSK) F
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
46.02
|
46.0212
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
42
|
A3969
|
RELVAR ELLIPTA 200MCG|25MCG INHR (GSK) FLUTICASONE|VILANTERO
|
FLUTICASONE|VILANTEROL
|
RELVAR ELLIPTA
|
30 DOSES
|
A
|
48.33
|
48.33
|
INHR
|
1
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
AVENTA BARBADOS
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A396A
|
AROFLO 250MCG | 25MCG INHR (ARP/AHI) FLUTICASON
|
FLUTICASONE|SALMETEROL
|
AROFLO
|
120 DOSES
|
A
|
32.27
|
32.27
|
INHALER
|
1
|
INHR
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2022-06-30
|
|
ORAL INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
2022-03-29
|
|
|
|
40
|
A396C
|
COMBIWAVE 250MCG | 25MCG INHR (GLP/ATB) FLUTICASONE | SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
C
|
32.62
|
32.62
|
INHALER
|
0
|
INHR
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2023-09-30
|
Change Local Agent
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
2022-03-22
|
|
|
|
40
|
A396D
|
Combiwave 250/25 MCG INHR(GLP/AHI)
|
Fluticasone|Salmeterol
|
COMBIWAVE
|
150 DOSES
|
A
|
$32.62
|
$32.62
|
INHALER
|
0
|
INHR
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTH CARE INC
|
B
|
4892
|
RESPIRATORY AGENTS MISSCELLEOUS
|
2023-08-15
|
2024-03-31
|
LOCAL AGENT CHANGED
|
ORAL INHALATION
|
|
RESPIRATORY TRACT AGENTS
|
2023-12-11
|
|
|
|
42
|
A396D
|
COMBIWAVE 250MCG|25MCG INHR (GLP) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
A
|
9.51
|
9.51
|
INHR
|
1
|
BOX
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL INHALATION
|
6
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
|
42
|
A396H
|
COMBIWAVE 250MCG|25MCG INHR (GLP) FLUTICASONE|SALMETEROL
|
FLUTICASONE|SALMETEROL
|
COMBIWAVE
|
150 DOSES
|
A
|
9.51
|
9.51
|
INHR
|
1
|
CNN
|
GLP
|
GLENMARK PHARMACEUTICALS LTD
|
CWS
|
CAPSULE WHOLESALE
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2026-04-01
|
2028-03-31
|
|
INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|
|
|
|
40
|
A4021
|
COMBIVENT 0.2MG/ML | 1MG/ML RESP SOL (BOE/STO) IPRATROPIUM | SALBUTAMOL
|
IPRATROPIUM|SALBUTAMOL
|
COMBIVENT
|
20X2.5ML
|
A
|
67.14
|
3.36
|
RESPIRATORY
|
20
|
BOTT
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
INHALATION
|
6
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
A4021
|
COMBIVENT 0.2MG/ML|1MG/ML RESP SOL (BOE) IPRATROPIUM|SALBUTA
|
IPRATROPIUM|SALBUTAMOL
|
COMBIVENT
|
20X2.5ML
|
A
|
69.15
|
3.4577
|
BOX
|
20
|
BOTT
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
INHALATION
|
6
|
RESPIRATORY AGENTS MISCELLANEOUS
|
|